A Home-Based, Remote-Clinician-Controlled, Physical Therapy Device Leads to Superior Outcomes When Compared to Standard Physical Therapy for Rehabilitation After Total Knee Arthroplasty

医学 关节炎 远程康复 增粘剂 最小临床重要差异 运动范围 物理疗法 可视模拟标度 康复 养生 患者满意度 关节置换术 骨关节炎 随机对照试验 外科 远程医疗 医疗保健 替代医学 病理 关节内 经济增长 经济
作者
Spencer Summers,Ryan Nunley,Eric Slotkin
出处
期刊:Journal of Arthroplasty [Elsevier]
卷期号:38 (3): 497-501
标识
DOI:10.1016/j.arth.2022.10.009
摘要

The optimal postoperative rehabilitation regimen following total knee arthroplasty (TKA) is not clearly defined. The advent of telerehabilitation offers potential for increased patient convenience and decreased cost, while maintaining similar outcomes to traditional physical therapy (PT). Therefore, we evaluated a novel, home-based, clinician-controlled, multi-modal evaluation and therapy device with telerehabilitation functionality for TKA.A total of 135 consecutive TKA patients receiving standard therapy protocol (STP) were compared to 135 consecutive patients receiving a home-based clinician-controlled therapy system (HCTS). Outcomes were assessed at 2, 6, and 12 weeks, including visual analog scale (VAS) for pain, knee injury and osteoarthritis outcome score JR (KOOS JR), and knee range of motion (ROM) measured by the same certified physical therapists.Postoperative knee ROM was greater in the HCTS group at all time points throughout the study period (P < .001 at 2, 6, and 12 weeks). VAS and the KOOS JR functional scores were statistically better (P < .001) in the HCTS group at all time points and exceeded the threshold for minimal clinically important difference (MCID) for both VAS and KOOS JR. There were significantly fewer cases of arthrofibrosis requiring manipulation under anesthesia (MUA) in the HCTS group (1.48 versus 4.44%).Following TKA, a novel, home-based, clinician-controlled, multi-modal therapy device was superior to standard PTduring the first 12 weeks postoperatively for ROM, KOOS JR, and VAS (with all scores exceeding the MCID) and had substantially fewer manipulations for arthrofibrosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
小趴菜完成签到 ,获得积分10
2秒前
努恩完成签到,获得积分10
4秒前
4秒前
萤火虫完成签到,获得积分10
4秒前
bxg发布了新的文献求助10
6秒前
海风完成签到,获得积分10
6秒前
怪叔叔完成签到,获得积分10
8秒前
liu完成签到,获得积分20
8秒前
foyefeng完成签到,获得积分10
9秒前
Silence发布了新的文献求助10
9秒前
果心纯发布了新的文献求助10
9秒前
pacify完成签到 ,获得积分10
11秒前
Yuan应助Tonald Yang采纳,获得10
12秒前
西柚子完成签到 ,获得积分10
12秒前
yuyuyuan完成签到,获得积分10
13秒前
畅快的念烟完成签到,获得积分10
14秒前
14秒前
WILAY889完成签到,获得积分10
14秒前
高乐多完成签到,获得积分10
15秒前
发嗲的雨筠完成签到,获得积分10
15秒前
科研通AI2S应助曾经的伯云采纳,获得10
16秒前
aaa完成签到 ,获得积分10
17秒前
ls完成签到 ,获得积分10
17秒前
17秒前
玛卡巴卡完成签到 ,获得积分10
18秒前
酷波er应助Yochamme采纳,获得10
20秒前
松山少林学武功完成签到 ,获得积分10
22秒前
小孟吖完成签到 ,获得积分10
23秒前
24秒前
王琳完成签到,获得积分10
24秒前
科研通AI5应助科研通管家采纳,获得10
28秒前
Loooong应助科研通管家采纳,获得10
28秒前
iNk应助科研通管家采纳,获得20
28秒前
Loooong应助科研通管家采纳,获得10
29秒前
Loooong应助科研通管家采纳,获得10
29秒前
CipherSage应助科研通管家采纳,获得10
29秒前
天天快乐应助科研通管家采纳,获得10
29秒前
shi hui应助科研通管家采纳,获得10
29秒前
Loooong应助科研通管家采纳,获得10
29秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Introduction to Micromechanics and Nanomechanics 2nd Edition 1000
Kelsen’s Legacy: Legal Normativity, International Law and Democracy 1000
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Crystal structures of UP2, UAs2, UAsS, and UAsSe in the pressure range up to 60 GPa 650
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3535346
求助须知:如何正确求助?哪些是违规求助? 3113817
关于积分的说明 9313502
捐赠科研通 2811746
什么是DOI,文献DOI怎么找? 1544420
邀请新用户注册赠送积分活动 719439
科研通“疑难数据库(出版商)”最低求助积分说明 711431